Barbara Richter

Olgahospital

Papers

3

Total Citations

123

H-Index

3

About

Dr. Barbara Richter is a leading gynecologic oncologist whose research has fundamentally shaped the clinical understanding and management of borderline ovarian tumors (BOT). Her work focuses on the critical interplay between patient age, surgical staging, and long-term prognosis for this rare ovarian malignancy. Dr. Richter’s major contributions stem from her integral role in the large-scale, multicenter AGO ROBOT study, a landmark pattern-of-care investigation that provided robust, evidence-based data where only small retrospective trials previously existed. Her most cited paper (75 citations) revealed significant age-dependent differences in BOT characteristics and outcomes, demonstrating that younger patients have distinct clinical profiles. A second highly influential study (42 citations) established the precise prognostic impact of individual surgical staging procedures, proving that incomplete staging is a negative prognostic factor. By clarifying which specific surgical steps are critical for patient survival, Dr. Richter’s work has directly informed clinical guidelines and operative standards, helping to optimize treatment strategies and improve outcomes for women diagnosed with this challenging disease.

Research Focus

Key Achievements

3
H-Index
3
Papers
123
Total Citations
41
Avg Citations/Paper
🏆 Most Cited Paper
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT study
75 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 41
🏛 Institutions: Olgahospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago